Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ · Healthcare
Rigel Pharmaceuticals, Inc. Total Liabilities 2016–2025
Rigel Pharmaceuticals, Inc. annual total liabilities history from 2021 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Rigel Pharmaceuticals, Inc. total liabilities as of December 31, 2025: 122.1M, a 24.01% decrease year-over-year.
- Rigel Pharmaceuticals, Inc. total liabilities for 2025 were 122.1M, a 24.01% decrease from 2024.
- Rigel Pharmaceuticals, Inc. total liabilities for 2024 were 160.7M, a 10.16% increase from 2023.
- Rigel Pharmaceuticals, Inc. total liabilities for 2023 were 145.9M, a 1.37% decrease from 2022.
- Rigel Pharmaceuticals, Inc. total liabilities for 2022 were 147.9M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Rigel Pharmaceuticals, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $122 |
| 2024 | $161 |
| 2023 | $146 |
| 2022 | $148 |
| 2021 | $137 |
Rigel Pharmaceuticals, Inc. Total Liabilities — FAQ
Rigel Pharmaceuticals, Inc. (RIGL) total liabilities over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RIGL's total liabilities history?
The chart and table above show Rigel Pharmaceuticals, Inc.'s total liabilities by year and by quarter, including the growth rate.